I Agree

We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms of Use.

PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: ONCIMMUNE ORD 1P ONC Announcements

ONCIMMUNE ORD 1P (ONC) Announcements

Date Time Source Announcement
01 Jul 2020 7:00 am
RNS
Authorisation for EarlyCDT Lung in Brazil
30 Jun 2020 7:00 am
RNS
Exercise of Options
09 Jun 2020 3:54 pm
RNS
Grant of Options and PDMR notification
08 Jun 2020 7:00 am
RNS
Holdings in Company
05 Jun 2020 2:00 pm
RNS
Price Monitoring Extension
  9:02 am
RNS
CORRECTION: Director/PDMR's Dealing
  7:00 am
RNS
Director/PDMR's Dealing
04 Jun 2020 7:00 am
RNS
Trading Update for 12 months to 31 May 2020
02 Jun 2020 4:09 pm
RNS
Holding(s) in Company
29 May 2020 2:40 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Notice of Trading Update
28 May 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Contract with Roche to Profile Autoantibodies
21 May 2020 7:00 am
RNS
EarlyCDT Lung Partnership Contract Signed
14 May 2020 7:00 am
RNS
Featured Presentation at ASCO 2020 Virtual Meeting
12 May 2020 7:00 am
RNS
Drug Development Collaboration Agreement Signed
06 May 2020 8:56 am
RNS
PDMR Dealing
04 May 2020 5:08 pm
RNS
Directorate Change
01 May 2020 10:32 am
RNS
Grant of Options and PDMR notification
24 Apr 2020 3:59 pm
RNS
Director/PDMR Shareholding
07 Apr 2020 11:41 am
RNS
PDMR Dealing
01 Apr 2020 10:31 am
RNS
PDMR Dealing
25 Mar 2020 12:42 pm
RNS
PDMR Dealing
20 Mar 2020 2:09 pm
RNS
Holding(s) in Company
18 Mar 2020 5:42 pm
RNS
Holding(s) in Company
  12:19 pm
RNS
PDMR Dealing
17 Mar 2020 10:24 am
RNS
NICE concludes review of EarlyCDT Lung
13 Mar 2020 11:42 am
RNS
Issue of Equity
12 Mar 2020 6:31 pm
RNS
PDMR / PCA Dealings
04 Mar 2020 7:00 am
RNS
US Commercial Launch
02 Mar 2020 3:35 pm
RNS
Director/PDMR's Dealing
21 Feb 2020 7:00 am
RNS
'Winning in Business in Spain' Award
18 Feb 2020 11:06 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
14 Feb 2020 4:41 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  11:55 am
RNS
Holding(s) in Company
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
12 Feb 2020 7:00 am
RNS
Half Year Report
28 Jan 2020 7:00 am
RNS
Lung Test More Cost Effective Compared to CT
27 Jan 2020 7:00 am
RNS
Notice of Capital Markets Update
23 Jan 2020 12:30 pm
RNS
Consortium of Liver Cancer Industry Leaders
07 Jan 2020 7:00 am
RNS
Notice of Half Year Results
  7:00 am
RNS
Change of Registered Address
12 Dec 2019 2:07 pm
RNS
Winner of BioNewsRound Award
29 Nov 2019 9:58 am
RNS
Results of Annual General Meeting
04 Nov 2019 2:46 pm
RNS
Notice of AGM and Posting of Annual Report
  7:00 am
RNS
Draw down of second tranche of credit facility
01 Nov 2019 7:10 am
RNS
Oncimmune and Biodesix seal deal
31 Oct 2019 7:00 am
RNS
Final Results
25 Oct 2019 7:00 am
RNS
Notice of Full Year Results ended May 2019
16 Oct 2019 5:01 pm
RNS
Oncimmune welcomes NHS review of cancer screenings
23 Sep 2019 7:00 am
RNS
Key appointments to further strengthen management
20 Sep 2019 2:32 pm
RNS
Appointment of Joint Broker
  7:00 am
RNS
EUR8.5m Credit Facility Secured
18 Sep 2019 7:00 am
RNS
Oncimmune to Present at 2019 CBIIC
09 Sep 2019 7:30 am
RNS
Positive Results for ECLS Trial Presentation
03 Sep 2019 12:00 pm
RNS
ECLS at 2019 World Conference for Lung Cancer
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close